In January 2025, FDA posted “Determining Recommended Acceptable Intake Limits for N-nitrosamine Impurities in Pharmaceuticals: Development and Application of the Carcinogenic Potency Categorization ...

A study by researchers from Bonn-Rhein-Sieg University of Applied Sciences and the University of Duisburg-Essen reported on ...

The blood pressure controlling tablets were found to have concerning levels of a cancer-causing impurity called N-Nitroso ...